SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Avanir Pharmaceuticals (AVN)
An SI Board Since December 1998
Posts SubjectMarks Bans Symbol
166 15 0 AVN
Emcee:  Mickey911 Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
141Looks to be set for a good move forward.Tadsamillionaire-8/8/2005
140AstraZeneca and AVANIR Announce Global Alliance to Discover and Develop Novel Renigel bates-7/11/2005
139Able Laboratories Signs Long-Term Lease for a 225,000 Square Foot Facility WedneTadsamillionaire-9/26/2003
138Able Laboratories Receives FDA Approval for Naproxen Sodium Tablets, USP 275 mg Tadsamillionaire-9/26/2003
137Able Laboratories Receives FDA Approval for Butalbital Acetaminophen Caffeine AnTadsamillionaire-9/26/2003
136AVANIR Reports Positive Phase II Clinical Data With Neurodex for Neuropathic PaiTadsamillionaire-6/12/2003
13510:28AM Avanir Pharma reports positive Phase II data (AVN) 2.20 +0.29: Results iTadsamillionaire-6/12/2003
134AVANIR Initiates Clinical Trial Program for Novel Allergy/Asthma Treatment MondaTadsamillionaire-3/22/2003
133AVANIR Announces Results Of Phase II/III Neurodex Trial DOW JONES NEWSWIRES SAmopgcw-6/21/2002
132BTK (biotech index) broke key support. Biotechs are under pressure and things loluis a. garcia-6/12/2002
131Abreva approved in Korea and Israel, stock rallied a bit on good volume. Short cluis a. garcia-5/31/2002
130luis: thanks for the update (please keep them coming)... i used to follow your pGeoff Goodfellow-5/29/2002
129Abreva Canadian approval is at hand. ADD 30 million new Abreva customers. ROW wiluis a. garcia-5/29/2002
128Dave, Have been out of AVN for almost a year. Se no future here unless they areMarc Phelan-5/17/2002
127<i>The stock has not been responding lately. Looks as if other things are Dave-5/16/2002
126Tim, The stock has not been responding lately. Looks as if other things are in Marc Phelan-3/27/2002
125AVANIR is developing a novel family of compounds for the treatment of allergy anTadsamillionaire-3/21/2002
124AVANIR CEO Reports Progress on Patent Extension Request for Abreva(TM) At CompanTadsamillionaire-3/21/2002
123AVANIR Pharmaceuticals Awarded $1 Million Research Grant To Develop a New DocosaTadsamillionaire-3/21/2002
122Wow, That is great news. Thanks... EOMTadsamillionaire-11/19/2001
121ORLANDO, Fla., Nov. 19 /PRNewswire/ -- AVANIR Pharmaceuticals (Amex: AVN - news)nigel bates-11/19/2001
120AVN's stem cell research relies on adult stem cells and not from embryos. AVTadsamillionaire-7/31/2001
119Peregrine Co-Sponsors International Symposia On Radiopharmaceutical Chemistry anTadsamillionaire-6/14/2001
118AVANIR Subsidiary Xenerex Biosciences and Peregrine Pharmaceuticals Announce ResTadsamillionaire-6/12/2001
117AVANIR Subsidiary Xenerex Biosciences Broadens Technology Platform By Licensing Tadsamillionaire-6/8/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News